Morning hair routine can expose individuals to harmful chemicals, study shows

Researchers conducted realistic-type hair care experiments to assess cyclic volatile methyl siloxane (cVMS) emissions and exposures during hair care product (HCP) use in a residential structure.

Generative AI revolutionizes antibiotic development against resistant pathogens

With nearly 5 million deaths linked to antibiotic resistance globally every year, new ways to combat resistant bacterial strains are urgently needed.

March 29, 2024

CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK – Biotech Investments

Issuer: CureVac / Key word(s): Study 01.08.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Dosing of

August 2, 2023

Study uncovers distinct blood protein signature in children with Long COVID

Distinct protein profiles linked to inflammation and angiogenesis found in children with Long COVID, paving the way for improved diagnostics and therapies.

January 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.